{"id":"NCT02822287","sponsor":"GlaxoSmithKline","briefTitle":"Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough","officialTitle":"An Open Label Study to Assess the Warming Sensation, Acceptability and Local Oral Tolerability of NCH-GSK Acetylcysteine 2% Oral Solution, Given as a Single Dose in Subjects Suffering From Productive Cough Due to Upper Respiratory Tract Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02","primaryCompletion":"2016-03","completion":"2016-03","firstPosted":"2016-07-04","resultsPosted":"2017-01-31","lastUpdate":"2017-01-31"},"enrollment":58,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Common Cold"],"interventions":[{"type":"DRUG","name":"Acetylcystine","otherNames":[]}],"arms":[{"label":"2% Acetylcystine Solution","type":"EXPERIMENTAL"}],"summary":"This is a 1-treatment arm, open label design. This 1-day study includes a screening on day of attendance at clinic, followed by a washout period of 30 minutes to 8 hours (if participants are eligible for dosing the same day). The study also includes a supervised dosing with 10 mL oral solution and a 1 hour in-clinic evaluation period.","primaryOutcome":{"measure":"Onset of Warming Sensation","timeFrame":"10 minutes post-dose","effectByArm":[{"arm":"2% Acetylcystine Solution","deltaMin":0.233,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":20},"locations":{"siteCount":1,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":57},"commonTop":[]}}